Top ▲

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

myosin light chain kinase 3

Click here for help

Target id: 2110

Nomenclature: myosin light chain kinase 3

Abbreviated Name: caMLCK

Family: Myosin Light Chain Kinase (MLCK) family

Contents:

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 819 16q11.2 MYLK3 myosin light chain kinase 3
Mouse - 795 8 C3 Mylk3 myosin light chain kinase 3
Rat - 786 19q11 Mylk3 myosin light chain kinase 3
Previous and Unofficial Names Click here for help
MLC kinase | cardiac-MLCK | cardiac-MyBP-C-associated Ca/CaM kinase
Database Links Click here for help
Alphafold Q32MK0 (Hs), Q3UIZ8 (Mm), E9PT87 (Rn)
BRENDA 2.7.11.18
ChEMBL Target CHEMBL4627 (Hs)
Ensembl Gene ENSG00000140795 (Hs), ENSMUSG00000031698 (Mm), ENSRNOG00000017546 (Rn)
Entrez Gene 91807 (Hs), 213435 (Mm), 291926 (Rn)
Human Protein Atlas ENSG00000140795 (Hs)
KEGG Enzyme 2.7.11.18
KEGG Gene hsa:91807 (Hs), mmu:213435 (Mm), rno:291926 (Rn)
OMIM 612147 (Hs)
Pharos Q32MK0 (Hs)
RefSeq Nucleotide NM_182493 (Hs), NM_175441 (Mm), NM_001110810 (Rn)
RefSeq Protein NP_872299 (Hs), NP_780650 (Mm), NP_001104280 (Rn)
UniProtKB Q32MK0 (Hs), Q3UIZ8 (Mm), E9PT87 (Rn)
Wikipedia MYLK3 (Hs)
Enzyme Reaction Click here for help
EC Number: 2.7.11.18
DiscoveRx KINOMEscan® screen Click here for help
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 1-2
Key to terms and symbols Click column headers to sort
Target used in screen: MLCK
Ligand Sp. Type Action Value Parameter
dovitinib Small molecule or natural product Hs Inhibitor Inhibition 8.7 pKd
KW-2449 Small molecule or natural product Hs Inhibitor Inhibition 8.4 pKd
lestaurtinib Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 7.9 pKd
tozasertib Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.8 pKd
sunitinib Small molecule or natural product Approved drug Ligand has a PDB structure Hs Inhibitor Inhibition 7.6 pKd
JNJ-28312141 Small molecule or natural product Hs Inhibitor Inhibition 7.4 pKd
SU-14813 Small molecule or natural product Hs Inhibitor Inhibition 7.4 pKd
PD-173955 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.8 pKd
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.8 pKd
PP-242 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.4 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »

References

Show »

1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]

2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]

How to cite this page

Myosin Light Chain Kinase (MLCK) family: myosin light chain kinase 3. Last modified on 18/08/2014. Accessed on 25/10/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2110.